» Articles » PMID: 1987673

Attenuated Neuropathology by Nilvadipine After Middle Cerebral Artery Occlusion in Rats

Overview
Journal Stroke
Date 1991 Jan 1
PMID 1987673
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the effects of nilvadipine, a calcium antagonist, on cerebral ischemia in rats. Under halothane anesthesia, 30 rats had a 3-0 nylon suture introduced through the extracranial internal carotid artery to occlude the left middle cerebral artery. Nilvadipine was dissolved in polyethylene glycol 400. Immediately following occlusion, group 1 rats (n = 10) were treated subcutaneously with vehicle and group 2 and 3 rats were treated with 1.0 (n = 10) and 3.2 (n = 10) mg/kg nilvadipine, respectively. Perfusion fixation was performed 24 hours later, and the histopathologic outcomes were quantified. In group 1 infarct volume was 28.2 +/- 11.4% of the total cerebral volume; in groups 2 and 3 infarct volumes were 25.5 +/- 11.6% (NS) and 13.9 +/- 9.2% (p less than 0.05 different from group 1), respectively. Nilvadipine decreased ischemic neuronal injury in a dose-dependent manner and may be of use in the treatment of cerebral ischemia.

Citing Articles

Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.

Satoh S, Ikegaki I, Suzuki Y, Asano T, Shibuya M, Hidaka H Br J Pharmacol. 1996; 118(7):1592-6.

PMID: 8842419 PMC: 1909837. DOI: 10.1111/j.1476-5381.1996.tb15579.x.


Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.

Garcia J, Yoshida Y, Chen H, Li Y, Zhang Z, Lian J Am J Pathol. 1993; 142(2):623-35.

PMID: 8434652 PMC: 1886726.


Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.

Brogden R, McTavish D Drugs Aging. 1995; 6(2):150-71.

PMID: 7711361 DOI: 10.2165/00002512-199506020-00007.